Loading...
Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant
No countermeasures currently exist for the prevention or treatment of the severe sequelae of Filovirus (such as Ebola virus; EBOV) infection. To overcome this limitation in our biodefense preparedness, we have designed monoclonal antibodies (mAbs) which could be used in humans as immunoprotectants f...
Na minha lista:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
National Academy of Sciences
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3251097/ https://ncbi.nlm.nih.gov/pubmed/22143789 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1108360108 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|